πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7563874

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560436

Methods of treating gastrointestinal inflammation

The Regents of the University of California Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560229

Methods of use of the enzymes of mycothiol synthesis

The Regents of the University of California Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557138

5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 p

The Regents of the University of California Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7556927

Methods for diagnosing, imaging and treating atherosclerotic disease

The Regents of the University of California Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557194

Antibody materials for an IBD-associated polypeptide

The Regents of the University of California Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553484

Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) mol

The Regents of the University of California Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544358

Treatment of acute lung injury, fibrosis and metastasis with antagonists of Ξ±vΞ²6

The Regents of the University of California Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544670

HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

The Regents of the University of California Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544486

Nell peptide expression systems and bone formation activity of nell peptide

The Regents of the University of California Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7537759

Modulating angiogenesis

The Regents of the University of California Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534613

Methods of treating parkinson's disease using viral vectors

The Regents of the University of California Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534440

Fusion molecules and methods for treatment of immune diseases

The Regents of the University of California Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534859

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administrat

The Regents of the University of California Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534764

Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

The Regents of the University of California Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531500

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531355

Methods and compositions for smooth muscle reconstruction

The Regents of the University of California Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531514

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527786

Methods for inhibiting the growth of cancer cells expressing PSCA

The Regents of the University of California Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527934

Labeled substrate conjugates for identifying enzyme inhibitors

The Regents of the University of California Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524944

Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-Ξ±

The Regents of the University of California Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521414

Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140

The Regents of the University of California Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521175

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

The Regents of the University of California Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517858

Prodrugs of pharmaceuticals with improved bioavailability

The Regents of the University of California Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted